Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q4 2024 Earnings Conference Call March 3, 2025 8:30 AM ET
Company Participants
Austin Murtagh – Precision AQ
Gregory Divis – Chief Executive Officer
Thomas McHugh – Chief Financial Officer
Conference Call Participants
François Brisebois – Oppenheimer
Poorna Kannan – Needham & Company
Oren Livnat – H.C. Wainwright & Co.
David Amsellem – Piper Sandler & Co.
Madhumita Yennawar – Leerink Partners
Myriam Belghiti – LifeSci Capital
David Hoang – Deutsche Bank AG
Brandon Folkes – Rodman & Renshaw Research
Operator
Greetings, and welcome to Avadel Pharmaceuticals’ Fourth Quarter and Business Update Conference Call. At this time, all participants are in a listen-only mode. Accompanying slides for this call can be found on Avadel’s Investor Relations website. A question-and-answer session will follow the formal presentation. As a reminder, this conference is being recorded.
It is now my pleasure to introduce Austin Murtagh with Precision AQ. Thank you. You may begin.
Austin Murtagh
Good morning, and thank you for joining us on our conference call to discuss Avadel’s fourth quarter and full-year 2024 results.
As a reminder, before we begin, the following presentation includes several matters that constitute forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those contemplated in such forward-looking statements.
These risks and uncertainties are described in Avadel’s public filings under the Exchange Act included in the company’s most recently filed Form 10-K and subsequent SEC filings. Except as required by law, Avadel undertakes no obligation to update or revise any forward-looking statements contained in this presentation to reflect new information, future events or otherwise.
On the call today are Greg Divis, Chief Executive Officer; and Tom McHugh, Chief Financial Officer.
Read the full article here
